In a recent interview with Gambling Insider, Nicholas Reville, co-founder of the Center for Addiction Science, Policy, and Research (CASPR), shared insights on the gambling industry's focus on post-addiction strategies, the misleading information provided to state legislators by operators, and the promising anecdotal evidence suggesting that GLP-1 medications may help treat gambling disorders.
On March 4, CASPR launched the 'Life Savings' initiative, aimed at tackling online gambling addiction. While the organization has historically concentrated on substance use disorders, its new Online Gambling Research Center has introduced a comprehensive 50-state scorecard, proposed model legislation, and an analysis of revenue losses from states that permit legal online gambling.
Reville, who also authors the Substack 'Recursive Adaptation,' emphasizes the need to address addiction as a pressing societal issue. His journey into this field began with a diverse background in public policy, neuroscience, and advocacy. He recounted a pivotal experience from 17 years ago when he mentored a young man in a Rhode Island juvenile prison, which profoundly influenced his understanding of addiction.
Reville's commitment to improving treatment options stems from witnessing the struggles of individuals like his mentee, who faced repeated cycles of addiction and incarceration. He expressed concern over the insufficient investment in innovative addiction therapies, questioning why curing addiction isn't prioritized at a national level. Despite some attention to addiction and overdose issues, he believes the societal costs remain largely unrecognized.
His dedication to this cause led to the founding of CASPR alongside Lindsay Holden, who shares a similar passion for addressing addiction. Together, they aim to approach addiction from a strategic perspective, inspired by successful treatments in other health domains that have transformed societal attitudes towards various problems.